Phase 4 Pancreatic Cancer Trial, Recruiting (NCT05245877)

Phase 4 Pancreatic Cancer Trial, Recruiting NCT05245877 Sponsor: Helsinki University Central Hospital Condition: Pancreatic Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05245877 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatic Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are scheduled to have a surgical procedure called a pancreaticoduodenectomy (removal of part of the pancreas and surrounding structures) or total pancreatectomy (removal of the entire pancreas), for any medical reason
People who are scheduled to have a distal pancreatectomy (removal of the tail end of the pancreas) where cancer is suspected

Who may not be able to join:

People who have been taking blood-thinning medications — such as heparin, low-molecular weight heparin, warfarin, or newer oral blood thinners — within the 30 days before surgery
People who need emergency surgery, for example due to trauma, infection, or pancreatitis
People under 18 years of age
People who have an allergy or another medical reason that prevents them from safely taking low-molecular weight heparin (a type of blood-thinning medication used as part of the trial)
People who are unable to provide written consent to participate
People for whom the planned pancreatic surgery does not go ahead (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +358-9-4711

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05245877

Sponsor: Helsinki University Central Hospital

Phase: Phase 4

Status: Recruiting

Condition: Pancreatic Cancer

Trial contact: +358-9-4711

More information: https://clinicaltrials.gov/study/NCT05245877

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are scheduled to have a surgical procedure called a pancreaticoduodenectomy (removal of part of the pancreas and surrounding structures) or total pancreatectomy (removal of the entire pancreas), for any medical reason
People who are scheduled to have a distal pancreatectomy (removal of the tail end of the pancreas) where cancer is suspected

Who may not be able to join:

People who have been taking blood-thinning medications — such as heparin, low-molecular weight heparin, warfarin, or newer oral blood thinners — within the 30 days before surgery
People who need emergency surgery, for example due to trauma, infection, or pancreatitis
People under 18 years of age
People who have an allergy or another medical reason that prevents them from safely taking low-molecular weight heparin (a type of blood-thinning medication used as part of the trial)
People who are unable to provide written consent to participate
People for whom the planned pancreatic surgery does not go ahead (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Helsinki University Central Hospital

Registry

ClinicalTrials.gov

Start date

17 August 2022

Est. completion

1 August 2026

Where this trial is recruiting

🇨🇦 Canada 🇫🇮 Finland 🇳🇴 Norway

Primary endpoints

Venous thromboembolism, number of patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov